Please note: The information displayed on this page might be outdated.
Grace Therapeutics: : self-funded - 2 Ph 3 programs in subarachnoid hemorrhage (NDA filing in 2019) and ataxia telangiecstasia, 1 Ph 2/3 in postherpetic neuralgia (PHN) [all approved orphan designation]; 2 add’l programs (trigeminal neuralgia & aortic aneurysm).
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Middle Atlantic
Listing
Private
Website:
Address:
2 Tower Center Blvd
Suite 1101G
East Brunswick, NJ 08816
United States

Company Participants at Boston Private Company Showcase

  • Bruce Hochstadt, M.D., Chief Operating Officer

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.